FAAH2

FAAH2
Identifiers
AliasesFAAH2, AMDD, fatty acid amide hydrolase 2
External IDsOMIM: 300654; GeneCards: FAAH2
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
3.5.1.99↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_174912
NM_001353840
NM_001353841

n/a

RefSeq (protein)

NP_777572
NP_001340769
NP_001340770

n/a

Location (UCSC)Chr X: 57.29 – 57.49 Mbn/a
PubMed searchn/a
Wikidata
View/Edit Human

Fatty acid amide hydrolase 2 or FAAH2 is a member of the serine hydrolase family of enzymes.

Fatty acid amide hydrolase 2 degrades many types of fatty acid amides, including the sleep-inducing oleamide and endocannabinoids such as anandamide. It has a tissue distribution quite distinct from the paralogous FAAH (or "FAAH1"). Compared to FAAH, it is less active on N-acyl ethanolamines (e.g. anandamide) and N-acyl taurines.

OrthoDB indicates that FAAH2 (as a gene distinct from FAAH) has orthologs all across Metazoa, with the notable exclusion of rodents. This complicates the translation of FAAH-related results from rodent models to human biology.

Clinical significance

Defects in this enzyme have been associated with neurologic and psychiatric disorders. Specifically, a Canadian male with autism, anxiety, severe dysarthria, and a number of other issues have a Ala458Ser mutation inherited from his healthy carrier mother. In cell models this mutation is associated with a decreased function of this gene. This patient has a very abnormal blood lipid composition consistent with a loss of function.

ClinVar reports a missense mutation that produces an early stop codon (Trp392Ter) is associated with Meckel-like syndrome.

UniProt Variant Viewer lists a large number of other variants found in surveyed human genomes. Several are predicted to have consequences by PolyPhen and/or SIFT.